TIAA CREF Investment Management’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$6.96M Buy
216,509
+8,713
+4% +$270K ﹤0.01% 1244
2018
Q4
$5.86M Sell
207,796
-5,661
-3% -$166K ﹤0.01% 1271
2018
Q3
$6.14M Sell
213,457
-22,486
-10% -$675K ﹤0.01% 1437
2018
Q2
$8.84M Buy
235,943
+29,564
+14% +$1.16M 0.01% 1229
2018
Q1
$8.11M Buy
206,379
+68,951
+50% +$2.52M 0.01% 1250
2017
Q4
$4.45M Buy
137,428
+9,792
+8% +$294K ﹤0.01% 1682
2017
Q3
$3.98M Sell
127,636
-11,741
-8% -$348K ﹤0.01% 1765
2017
Q2
$3.9M Buy
139,377
+5,033
+4% +$114K ﹤0.01% 1757
2017
Q1
$2.3M Buy
134,344
+4,884
+4% +$68.4K ﹤0.01% 2047
2016
Q4
$1.57M Buy
129,460
+10,318
+9% +$134K ﹤0.01% 2318
2016
Q3
$1.89K Buy
119,142
+1,237
+1% +$18.6K ﹤0.01% 2211
2016
Q2
$1.52M Buy
117,905
+68,195
+137% +$1.07M ﹤0.01% 2280
2016
Q1
$944K Sell
49,710
-8,721
-15% -$158K ﹤0.01% 2505
2015
Q4
$1.31M Sell
58,431
-2,749
-4% -$54.4K ﹤0.01% 2408
2015
Q3
$1.43M Buy
61,180
+5,539
+10% +$153K ﹤0.01% 2351
2015
Q2
$1.59M Buy
55,641
+33,037
+146% +$866K ﹤0.01% 2445
2015
Q1
$584K Buy
22,604
+8,721
+63% +$199K ﹤0.01% 2875
2014
Q4
$258K Buy
13,883
+1,593
+13% +$28.7K ﹤0.01% 3072
2014
Q3
$190K Buy
+12,290
New +$185K ﹤0.01% 3089

Other funds holding XENT

TIAA CREF Investment Management's XENT Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Intersect ENT, Inc (XENT) stake by 4.2% in Q1 2019, buying an estimated $270K and bringing the position to 216,509 shares worth $6.96M. The position accounts for ﹤0.01% of the portfolio, ranked #1244.

TIAA CREF Investment Management first reported a position in XENT in Q3 2014 and has held it in 19 quarters since. The position peaked at $8.84M in Q2 2018. 136 funds tracked by Wall St. Rank hold XENT as of Q1 2019.

  • TIAA CREF Investment Management held 216,509 shares of Intersect ENT, Inc worth $6.96M as of Q1 2019.
  • TIAA CREF Investment Management bought 8,713 Intersect ENT, Inc shares in Q1 2019, an estimated $270K.
  • Intersect ENT, Inc made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1244 holding.
  • TIAA CREF Investment Management first reported a position in Intersect ENT, Inc in Q3 2014 and has held it in 19 quarters since.
  • TIAA CREF Investment Management's Intersect ENT, Inc position peaked at $8.84M in Q2 2018.
  • 136 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.